Divis Laboratories Ltd vs Sanofi India Ltd Stock Comparison
Divis Laboratories Ltd vs Sanofi India Ltd Stock Comparison
Last Updated on: May 05, 2026
Key Highlights
The Latest Trading Price of Divis Laboratories Ltd is ₹ 6653 as of 05 May 15:30
. The p/e ratio of Divis Laboratories Ltd changed from 48.6 to 69.8 over 5 quarters. This represents a CAGR of 33.59%
The p/e ratio of Sanofi India Ltd changed from 30.8 to 0 over 7 quarters. This represents a CAGR of -100.00%
The market cap of Divis Laboratories Ltd changed from ₹ 96366 crore to ₹ 153257 crore over 5 quarters. This represents a CAGR of 44.94%
The market cap of Sanofi India Ltd changed from ₹ 18578 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00%
The revenue of Divis Laboratories Ltd for the Dec '25 is ₹ 2692 crore as compare to the Sep '25 revenue of ₹ 2860 crore. This represent the decline of -5.87% The revenue of Sanofi India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Divis Laboratories Ltd for the Dec '25 is ₹ 904 crore as compare to the Sep '25 ebitda of ₹ 1033 crore. This represent the decline of -12.49% The ebitda of Sanofi India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Divis Laboratories Ltd changed from ₹ 430 crore to ₹ 583 crore over 7 quarters. This represents a CAGR of 19.00%
The net profit of Sanofi India Ltd changed from ₹ 136.6 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00%
The dividend payout of Divis Laboratories Ltd changed from 27.16 % to 35.99 % over 5 quarters. This represents a CAGR of 25.26%
The dividend payout of Sanofi India Ltd changed from 119.34 % to 0 % over 10 quarters. This represents a CAGR of -100.00%
.
About Divis Laboratories Ltd
Divi's Laboratories Limited is one of the leading pharmaceutical companies in the world, manufacturing Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceuticals.
The Company is one of the world's largest API companies, with two manufacturing units and a market presence across 100 countries.
It is engaged in the manufacture of Active Pharmaceutical ingredients (API's), Intermediates and Nutraceutical ingredients with predominance in exports.
In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.
It is among the largest pharmaceutical companies in India with a portfolio of approx.
About Sanofi India Ltd
Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs s and pharmaceuticals.
It has its own manufacturing facility at Goa.
FAQs for the comparison of Divis Laboratories Ltd and Sanofi India Ltd
Which company has a larger market capitalization, Divis Laboratories Ltd or Sanofi India Ltd?
Market cap of Divis Laboratories Ltd is 176,617 Cr while Market cap of Sanofi India Ltd is 8,111 Cr
What are the key factors driving the stock performance of Divis Laboratories Ltd and Sanofi India Ltd?
The stock performance of Divis Laboratories Ltd and Sanofi India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Divis Laboratories Ltd and Sanofi India Ltd?
As of May 5, 2026, the Divis Laboratories Ltd stock price is INR ₹6653.05. On the other hand, Sanofi India Ltd stock price is INR ₹3522.25.
How do dividend payouts of Divis Laboratories Ltd and Sanofi India Ltd compare?
To compare the dividend payouts of Divis Laboratories Ltd and Sanofi India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.